Top 5 MFs that created wealth in last decade
Top 5 MFs that created wealth in last decade

Top 5 MFs that created wealth in last decade

Henil Shah Article rating: 3.0

Out of 542 mutual funds, there were 230 funds, which gave double-digit annualised returns in the last decade. Read on to find out more.

Unichem Labs gets USFDA nod to market generic version of Otezla; stock ends 5 per cent higher
Unichem Labs gets USFDA nod to market generic version of Otezla; stock ends 5 per cent higher

Unichem Labs gets USFDA nod to market generic version of Otezla; stock ends 5 per cent higher

Anthony Fernandes Article rating: 5.0

Unichem Laboratories Ltd, an international, integrated, speciality pharmaceutical company informed the exchanges on Friday that it has received ANDA approval for its Apremilast tablets in the strengths of 10 mg, 20 mg & 30 mg by United States Food & Drug Administration (USFDA).  

Bears dominate Sensex & Nifty; Tejas Networks gains 9 per cent, KRBL jumps 8 per cent, ONGC slips, PSU Bank index sheds 5 per cent
Bears dominate Sensex & Nifty; Tejas Networks gains 9 per cent, KRBL jumps 8 per cent, ONGC slips, PSU Bank index sheds 5 per cent

Bears dominate Sensex & Nifty; Tejas Networks gains 9 per cent, KRBL jumps 8 per cent, ONGC slips, PSU Bank index sheds 5 per cent

Geyatee Deshpande Article rating: 3.8

On Friday as well, the markets indicated bearish investor sentiments as Sensex ends below 51,000, declining by 434.93 points or 0.85 per cent to settle at 50,889.76 levels while Nifty fell by 137.20 points or 0.91 per cent to close at 14,981.75 levels.   

MFs that are likely to gain from cyclical bets
MFs that are likely to gain from cyclical bets

MFs that are likely to gain from cyclical bets

Henil Shah Article rating: 4.8

A lot of asset managers are getting positive on cyclicals. Read onto find out more about the funds that are likely to gain from cyclical bets.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Ganesh Pawar Article rating: 3.7

The market opened in red on February 19, 2021, overall volumes in futures & options currently stand at 8,17,16,388 contracts with a turnover of Rs. 80,21,078.07 crore.

Firstsource Solutions share inches up as business relations expand
Firstsource Solutions share inches up as business relations expand

Firstsource Solutions share inches up as business relations expand

Shreya Chaware Article rating: 3.6

On Friday, Firstsource’s company, PatientMatters announced that Mon Health System, which serves communities in West Virginia, has selected the company’s Intelli Advisor Consulting Services.  

Indian & global macroeconomic weekly
Indian & global macroeconomic weekly

Indian & global macroeconomic weekly

Srinivasa Sharan Article rating: 5.0

In the local economic news, even as the overall consumer inflation for January eased to a 16-month low of 4.09 per cent in January from 4.59 per cent in December, core inflation (a better measure of medium-term inflation), which excludes the effects of volatile food and fuel prices,

Nifty bounces back from days low; Tata Chemicals CE strikes witness unusual activity
Nifty bounces back from days low; Tata Chemicals CE strikes witness unusual activity

Nifty bounces back from days low; Tata Chemicals CE strikes witness unusual activity

Karan Dsij Article rating: 4.6

Stocks from the consumer food industry were also seen buzzing as Hindustan Foods jumped nearly 10 per cent while Tasty Bite Eatables soared 2.5 per cent.   On the stock options’ front, unusual activity was seen in Tata Chemicals CE strikes.

RSS
First19511952195319541956195819591960Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR